In practice, the BDNF mimetics studied so far have not shown seizure-promoting effects at therapeutic doses, and PE-22-28 actually demonstrates seizure-protective properties
This difference reflects their individual stability testing, formulation specifics, and quality assurance practices
Our experience shows that under ideal conditionsspecifically, consistent refrigeration at 2-8C (36-46F) and protection from lighta lyophilized GHK-Cu vial can maintain its declared potency for up to two years, sometimes even longer, from its manufacture date
Lancet 406 , 135148 (2025)
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia): full and distilled review